Le Lézard
Classified in: Health
Subject: SVY

Orthopedic Prosthetics - Medical Devices Pipeline Assessment, 2017



LONDON, Oct. 6, 2017 /PRNewswire/ -- Summary
GlobalData's Medical Devices sector report, "Orthopedic Prosthetics - Medical Devices Pipeline Assessment, 2017" provides an overview of Orthopedic Prosthetics currently in pipeline stage.



Download the full report: https://www.reportbuyer.com/product/3524433



The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Orthopedic Prosthetics pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
- Extensive coverage of the Orthopedic Prosthetics under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Orthopedic Prosthetics and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy
The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Orthopedic Prosthetics under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date

Download the full report: https://www.reportbuyer.com/product/3524433

About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
https://www.reportbuyer.com  

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer


These press releases may also interest you

at 21:37
BD (Becton, Dickinson and Company) announced today that, in connection with its previously announced offers to exchange (the "Exchange Offers") any and all outstanding 4.400% Notes due 2021, 3.000% Notes due 2026 and 6.700% Notes due 2026...

at 19:33
Resverlogix Corp. ("Resverlogix" or the "Company") announced today that it has filed its unaudited interim Consolidated Financial Statements and Management's Discussion & Analysis for the quarter ended October 31, 2017 with Canadian securities...

at 19:06
Health Canada is advising Canadians that the following products may pose serious health risks. For more information, including what Canadians should do, visit the online safety alert.   Unauthorized health products Product & Promoted Use...

at 19:03
ICC Labs Inc. ("ICC Labs" or the "Company") , a fully licensed producer and distributor of medicinal cannabinoid extracts, recreational cannabis and industrial hemp products in Uruguay, is pleased to announce it has changed its name from ICC...

at 18:37
Update This notice is being updated to include additional provinces, Ontario and Nova Scotia, which have reported illnesses linked to this outbreak. Since the original notice was issued, there are nine additional cases of E. coli that have been...

at 18:25
MiMedx Group, Inc. , the leading biopharmaceutical company developing and marketing regenerative and therapeutic biologics utilizing human placental tissue allografts and patent-protected processes for multiple sectors of healthcare, announced today...




News published on 6 october 2017 at 10:24 and distributed by: